Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
about
Aldara activates TLR7-independent immune defenceDepigmentation therapies for normal skin in vitiligo universalis.Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell LinesThe small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.Immune response modifiers--mode of action.TLR7 and TLR8 as targets in cancer therapy.Bowen's disease - a review of newer treatment options.Resiquimod, a topical drug for viral skin lesions and skin cancer.Diallyl trisulfide induces apoptosis of human basal cell carcinoma cells via endoplasmic reticulum stress and the mitochondrial pathway.Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial.Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.Immunohistochemical evaluation of p53 and Ki67 expression in skin epithelial tumors.Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.XZ-1 regulates cell apoptosis of gastric epithelial dysplasia via NF-κB/p53/Ki67 signaling pathway.
P2860
Q28286677-B739307E-1B73-408E-8F38-64031B87D3D4Q33739817-30697F83-8FF3-452A-B72D-F8A39917A397Q34401302-C57DAE3F-9B78-4264-8830-D551CBCF4ECFQ34744159-EBCE81BD-071E-42AF-99DC-AD8DA0F1CD4CQ36218717-E28C5876-53C4-4F98-B6A2-FF2B19CC96D4Q36379372-8BC6F775-949E-4AE4-8C71-CE3FD3F8C2D2Q36455993-5B74C817-C8B5-4C4A-8F84-517D48E03133Q37051014-C2A01D16-1E19-4C4C-86C2-EF99E4BF7902Q37390392-45B7AA36-DFDB-44BA-9A95-5CEA4A4E1CC4Q38064483-913F2379-963B-4BDF-A6AC-DC6E408CCFAFQ39361797-AB89CB75-DF58-4352-A258-EC8FEFAA6630Q40089107-3290CF0F-1A7A-4E10-BBD4-447206A5EFA9Q40979821-F4E55CED-23C8-4112-A101-04F414C081C3Q41187552-4AFC3C90-02AE-4B2C-84DC-D868C6369B22Q46887182-17BE9CD8-FF6F-4DA0-AB58-52026F62D5AEQ55027115-5B995977-60C0-4728-96CC-BC90A0BDE67C
P2860
Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@en
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@nl
type
label
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@en
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@nl
prefLabel
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@en
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@nl
P2093
P2860
P1476
Efficacy of imiquimod for the ...... asal cell carcinoma apoptosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2004.06094.X
P407
P577
2004-09-01T00:00:00Z